BUZZ-Valeant Pharmaceuticals International Inc: Set to continue gain

Tue Nov 3, 2015 8:49am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Canadian drugmaker's U.S.-listed shares up 5.1 pct at $105.55 premarket

** Shares set to continue gain for second straight day

** On Monday, short-seller Citron Research said it was taking a back seat in investigating Valeant, but not backing down from earlier allegations (

** Stock closed up 7 pct on Monday

** Up to Monday's close, Valeant's stock had tumbled nearly 31.5 pct since Oct. 21, when Citron said the Canadian company was using specialty pharmacies to inflate revenue